181 related articles for article (PubMed ID: 11358978)
1. CD1d-reactive T-cell activation leads to amelioration of disease caused by diabetogenic encephalomyocarditis virus.
Exley MA; Bigley NJ; Cheng O; Tahir SM; Smiley ST; Carter QL; Stills HF; Grusby MJ; Koezuka Y; Taniguchi M; Balk SP
J Leukoc Biol; 2001 May; 69(5):713-8. PubMed ID: 11358978
[TBL] [Abstract][Full Text] [Related]
2. Cutting edge: activation of NK T cells by CD1d and alpha-galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype.
Singh N; Hong S; Scherer DC; Serizawa I; Burdin N; Kronenberg M; Koezuka Y; Van Kaer L
J Immunol; 1999 Sep; 163(5):2373-7. PubMed ID: 10452969
[TBL] [Abstract][Full Text] [Related]
3. CD1d mediates T-cell-dependent resistance to secondary infection with encephalomyocarditis virus (EMCV) in vitro and immune response to EMCV infection in vivo.
Ilyinskii PO; Wang R; Balk SP; Exley MA
J Virol; 2006 Jul; 80(14):7146-58. PubMed ID: 16809320
[TBL] [Abstract][Full Text] [Related]
4. Resistance to malarial infection is achieved by the cooperation of NK1.1(+) and NK1.1(-) subsets of intermediate TCR cells which are constituents of innate immunity.
Mannoor MK; Weerasinghe A; Halder RC; Reza S; Morshed M; Ariyasinghe A; Watanabe H; Sekikawa H; Abo T
Cell Immunol; 2001 Aug; 211(2):96-104. PubMed ID: 11591113
[TBL] [Abstract][Full Text] [Related]
5. Innate immune response to encephalomyocarditis virus infection mediated by CD1d.
Exley MA; Bigley NJ; Cheng O; Shaulov A; Tahir SM; Carter QL; Garcia J; Wang C; Patten K; Stills HF; Alt FW; Snapper SB; Balk SP
Immunology; 2003 Dec; 110(4):519-26. PubMed ID: 14632651
[TBL] [Abstract][Full Text] [Related]
6. Invariant and noninvariant natural killer T cells exert opposite regulatory functions on the immune response during murine schistosomiasis.
Mallevaey T; Fontaine J; Breuilh L; Paget C; Castro-Keller A; Vendeville C; Capron M; Leite-de-Moraes M; Trottein F; Faveeuw C
Infect Immun; 2007 May; 75(5):2171-80. PubMed ID: 17353286
[TBL] [Abstract][Full Text] [Related]
7. Identification of canine natural CD3-positive T cells expressing an invariant T-cell receptor alpha chain.
Yasuda N; Masuda K; Tsukui T; Teng A; Ishii Y
Vet Immunol Immunopathol; 2009 Dec; 132(2-4):224-31. PubMed ID: 19748683
[TBL] [Abstract][Full Text] [Related]
8. CD1d-restricted NKT cell activation enhanced homeostatic proliferation of CD8+ T cells in a manner dependent on IL-4.
Ueda N; Kuki H; Kamimura D; Sawa S; Seino K; Tashiro T; Fushuku K; Taniguchi M; Hirano T; Murakami M
Int Immunol; 2006 Sep; 18(9):1397-404. PubMed ID: 16914507
[TBL] [Abstract][Full Text] [Related]
9. Mediastinal lymph node CD8alpha- DC initiate antigen presentation following intranasal coadministration of alpha-GalCer.
Ko SY; Lee KA; Youn HJ; Kim YJ; Ko HJ; Heo TH; Kweon MN; Kang CY
Eur J Immunol; 2007 Aug; 37(8):2127-37. PubMed ID: 17615581
[TBL] [Abstract][Full Text] [Related]
10. Immediate antigen-specific effector functions by TCR-transgenic CD8+ NKT cells.
Wingender G; Berg M; Jüngerkes F; Diehl L; Sullivan BA; Kronenberg M; Limmer A; Knolle PA
Eur J Immunol; 2006 Mar; 36(3):570-82. PubMed ID: 16506291
[TBL] [Abstract][Full Text] [Related]
11. Multiple defects in antigen presentation and T cell development by mice expressing cytoplasmic tail-truncated CD1d.
Chiu YH; Park SH; Benlagha K; Forestier C; Jayawardena-Wolf J; Savage PB; Teyton L; Bendelac A
Nat Immunol; 2002 Jan; 3(1):55-60. PubMed ID: 11731798
[TBL] [Abstract][Full Text] [Related]
12. Prevention of injury-induced suppression of T-cell immunity by the CD1d/NKT cell-specific ligand alpha-galactosylceramide.
Tulley JM; Palmer JL; Gamelli RL; Faunce DE
Shock; 2008 Feb; 29(2):269-77. PubMed ID: 17693934
[TBL] [Abstract][Full Text] [Related]
13. NKT cells derive from double-positive thymocytes that are positively selected by CD1d.
Gapin L; Matsuda JL; Surh CD; Kronenberg M
Nat Immunol; 2001 Oct; 2(10):971-8. PubMed ID: 11550008
[TBL] [Abstract][Full Text] [Related]
14. Aging is associated with a rapid decline in frequency, alterations in subset composition, and enhanced Th2 response in CD1d-restricted NKT cells from human peripheral blood.
Jing Y; Gravenstein S; Chaganty NR; Chen N; Lyerly KH; Joyce S; Deng Y
Exp Gerontol; 2007 Aug; 42(8):719-32. PubMed ID: 17368996
[TBL] [Abstract][Full Text] [Related]
15. Activation of invariant NKT cells confers protection against Chlamydia trachomatis-induced arthritis.
Bharhani MS; Chiu B; Na KS; Inman RD
Int Immunol; 2009 Jul; 21(7):859-70. PubMed ID: 19477915
[TBL] [Abstract][Full Text] [Related]
16. CD1d expression on hemopoietic cells promotes CD4+ Th1 response in coxsackievirus B3 induced myocarditis.
Huber SA
Virology; 2006 Aug; 352(1):226-36. PubMed ID: 16730774
[TBL] [Abstract][Full Text] [Related]
17. Nonredundant roles for CD1d-restricted natural killer T cells and conventional CD4+ T cells in the induction of immunoglobulin E antibodies in response to interleukin 18 treatment of mice.
Yoshimoto T; Min B; Sugimoto T; Hayashi N; Ishikawa Y; Sasaki Y; Hata H; Takeda K; Okumura K; Van Kaer L; Paul WE; Nakanishi K
J Exp Med; 2003 Apr; 197(8):997-1005. PubMed ID: 12695491
[TBL] [Abstract][Full Text] [Related]
18. Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes.
Sharif S; Arreaza GA; Zucker P; Mi QS; Sondhi J; Naidenko OV; Kronenberg M; Koezuka Y; Delovitch TL; Gombert JM; Leite-De-Moraes M; Gouarin C; Zhu R; Hameg A; Nakayama T; Taniguchi M; Lepault F; Lehuen A; Bach JF; Herbelin A
Nat Med; 2001 Sep; 7(9):1057-62. PubMed ID: 11533711
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of HIV DNA vaccine immunogenicity by the NKT cell ligand, alpha-galactosylceramide.
Huang Y; Chen A; Li X; Chen Z; Zhang W; Song Y; Gurner D; Gardiner D; Basu S; Ho DD; Tsuji M
Vaccine; 2008 Mar; 26(15):1807-16. PubMed ID: 18329757
[TBL] [Abstract][Full Text] [Related]
20. Prevention of autoimmunity by targeting a distinct, noninvariant CD1d-reactive T cell population reactive to sulfatide.
Jahng A; Maricic I; Aguilera C; Cardell S; Halder RC; Kumar V
J Exp Med; 2004 Apr; 199(7):947-57. PubMed ID: 15051763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
